close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Home・Aandelen Lijst・CEL-SCI Corp
Search

CEL-SCI Corp

Gesloten

SectorGezondheidszorg

4.32

Prijsupdate 26 feb 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.25

Max

4.52

Belangrijke statistieken

By Trading Economics

Inkomsten

631K

-5.5M

EPS

-0.86

EBITDA

607K

-4.4M

Dividenden

By Dow Jones

Volgende Winsten

14 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.8M

37M

Vorige openingsprijs

4.32

Vorige sluitingsprijs

4.32

Nieuwssentiment

By Acuity

25%

75%

50 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

N/A / 0.2494 Steun & Weerstand

CEL-SCI Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 feb 2026, 22:04 UTC

Winsten

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

DJ

Lezen

26 feb 2026, 23:55 UTC

Marktinformatie

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

DJ

Lezen

26 feb 2026, 23:40 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

DJ

Lezen

26 feb 2026, 23:37 UTC

Marktinformatie

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

DJ

Lezen

26 feb 2026, 23:32 UTC

Winsten

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

DJ

Lezen

26 feb 2026, 23:19 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

DJ

Lezen

26 feb 2026, 23:18 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

DJ

Lezen

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

DJ

Lezen

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Gives Up in Bidding War Over Warner -- Market Talk

DJ

Lezen

26 feb 2026, 23:01 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

DJ

Lezen

26 feb 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

DJ

Lezen

26 feb 2026, 22:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

26 feb 2026, 22:43 UTC

Marktinformatie

RBA Hike In March Is Being Underpriced -- Market Talk

DJ

Lezen

26 feb 2026, 22:33 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

DJ

Lezen

26 feb 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

DJ

Lezen

26 feb 2026, 22:13 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Bidding War Over Warner Bros. Set to Continue -- Market Talk

DJ

Lezen

26 feb 2026, 21:59 UTC

Winsten

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

DJ

Lezen

26 feb 2026, 21:58 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

DJ

Lezen

26 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

26 feb 2026, 21:49 UTC

Winsten

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

DJ

Lezen

26 feb 2026, 21:45 UTC

Winsten

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Expects Market to Remain Highly Competitive

DJ

Lezen

26 feb 2026, 21:44 UTC

Winsten

Coles Says Supermarket Customers Remain Value Oriented

DJ

Lezen

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

DJ

Lezen

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

DJ

Lezen

26 feb 2026, 21:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

DJ

Lezen

26 feb 2026, 21:41 UTC

Winsten
Acquisities, Fusies, Overnames

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

CEL-SCI Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan CEL-SCI Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 0.2494Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bullish Evidence

There is one bullish event.

Lange Termijn

Weak Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

50 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,020.69

↓-0.81%

JNJ

Johnson and Johnson

243.4

↓-0.72%

ABBV

AbbVie Inc

224.52

↓-1.08%

NVS

Novartis AG

165.19

↓-0.73%

MRK

Merck & Co Inc.

119.22

↓-2.61%
help-icon Live chat